Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 6.425% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a CN(Cc1ccccn1)Cc1nc(Cc2ccccc2Cl)no1
b O=C(CN1CCCC1)Nc1ccc(NC(=O)Nc2ccccc2)cc1
c O=C(Cc1csc(Nc2nc(=S)[nH]c3ccccc23)n1)NCc1cccc(Cl)c1
Answer: b. O=C(CN1CCCC1)Nc1ccc(NC(=O)Nc2ccccc2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CN1CCCC1)Nc1ccc(NC(=O)Nc2ccccc2)cc1
O=C(CN1CCCC1)Nc1ccc(NC(=O)Nc2ccccc2)cc1
N-[4-(phenylcarbamoylamino)phenyl]-2-pyrrolidin-1-ylacetamide